Evidence map›Paper›PMID 33420219›Full record

ArticleScientific reports2021

Salivary microbiome with gastroesophageal reflux disease and treatment.

Nadia Kawar, Seon Gyeong Park, Joel L Schwartz, Nicholas Callahan, Ales Obrez, Bin Yang, Zhengjia Chen, Guy R Adami

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. The Human Microbiome-A Physiologic Perspective.Comprehensive Physiology · 2024
    Review
  18. Article
  19. Review article: Diagnosis and management of laryngopharyngeal reflux.Alimentary pharmacology & therapeutics · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nadia KawarDepartment of Periodontics, College of Dentistry, University of Illinois at Chicago, Chicago, IL, USA.
Seon Gyeong ParkDepartment of Periodontics, College of Dentistry, University of Illinois at Chicago, Chicago, IL, USA.
Joel L SchwartzDepartment of Oral Medicine and Diagnostics, College of Dentistry, University of Illinois at Chicago, 801 South Paulina Street, Chicago, IL, 60612, USA.
Nicholas CallahanDepartment of Oral and Maxillofacial Surgery, College of Dentistry, University of Illinois at Chicago, Chicago, IL, USA.
Ales ObrezDepartment of Prosthodontics & Implant Innovation, College of Dentistry, University of Illinois at Chicago, Chicago, IL, USA.
Bin YangDepartment of Prosthodontics & Implant Innovation, College of Dentistry, University of Illinois at Chicago, Chicago, IL, USA.
Zhengjia ChenDivision of Epidemiology and Biostatistics, School of Public Health, University of Illinois At Chicago, Chicago, IL, USA.
Guy R AdamiDepartment of Oral Medicine and Diagnostics, College of Dentistry, University of Illinois at Chicago, 801 South Paulina Street, Chicago, IL, 60612, USA. gadami@uic.edu.
University of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effect of oral microbial composition on periodontal health and on systemic health has been, and is being established. The oral microbiome, in turn, can be altered by local and systemic diseases and conditions. Gastroesophageal reflux disease (GERD), has been associated with increased acidity in the oral cavity resulting in dental erosion, and controversially a reduced risk of periodontal disease. We hypothesized that presence of GERD was linked to a modified microbial profile in untreated GERD patients and that the use of proton pump inhibitor (PPI) drugs: potent disruptors of gut microbiome, in GERD patients might result in a salivary microbiome that is further distinct. Untreated GERD patients showed multiple differences in salivary microbiome as compared to healthy controls. Taxa found at lower levels related to the presence of GERD not treated by PPI included: Prevotella melaninogenica, Prevotella pallens, Leptotrichia, and Solobacterium moorei and thirteen others. In contrast, GERD patients chronically using PPI showed minimal differences in salivary taxa compared to healthy controls not using PPI.

Indexed as

FemaleGastroesophageal RefluxHumansMaleMicrobiotaMiddle AgedProton Pump InhibitorsSalivaProton Pump Inhibitors

Identifiers

PMID33420219
PMCPMC7794605
OpenAlexW3120856427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.